Literature DB >> 20621169

Controlled removal of a nonviral episomal vector from transfected cells.

Sina Rupprecht1, Claudia Hagedorn, Davide Seruggia, Terese Magnusson, Ernst Wagner, Manfred Ogris, Hans J Lipps.   

Abstract

An ideal vector to be used in gene therapy should allow long-term and regulated expression of the therapeutic sequence, but in many cases, it would be most desirable to remove all ectopic vector sequences from the cell once expression is no longer required. The vector pEPI is the first nonviral autonomous replicon that was constructed for mammalian cells. It represents a minimal model system to study the epigenetic regulation of replication and transcription but is also regarded as a promising alternative to currently used viral vector systems in gene therapy. Its function relies on a transcription unit linked to an S/MAR sequence. We constructed an inducible pEPI vector system based on the Tet ON system in which transcription is switched on in the presence of doxycycline. We show that for vector replication and long-term maintenance an ongoing transcription running into the S/MAR element is required. Once established, the vector is lost from the cell upon switching off transcription from the gene linked to the S/MAR. This feature provides not only controlled transgene expression but also the possibility to remove all vector molecules from the cells upon demand. This inducible episomal nonviral vector system will find broad application in gene therapy but also in reprogramming of somatic cells or modification of stem cells. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20621169     DOI: 10.1016/j.gene.2010.07.001

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

1.  Genomic cis-acting Sequences Improve Expression and Establishment of a Nonviral Vector.

Authors:  Claudia Hagedorn; Michael N Antoniou; Hans J Lipps
Journal:  Mol Ther Nucleic Acids       Date:  2013-09-03       Impact factor: 10.183

2.  Development and validation of non-integrative, self-limited, and replicating minicircles for safe reporter gene imaging of cell-based therapies.

Authors:  John A Ronald; Lorena Cusso; Hui-Yen Chuang; Xinrui Yan; Anca Dragulescu-Andrasi; Sanjiv Sam Gambhir
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

3.  Genome-wide profiling of S/MAR-based replicon contact sites.

Authors:  Claudia Hagedorn; Andreas Gogol-Döring; Sabrina Schreiber; Jörg T Epplen; Hans J Lipps
Journal:  Nucleic Acids Res       Date:  2017-07-27       Impact factor: 16.971

4.  Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor Models.

Authors:  Matthias Bozza; Edward W Green; Elisa Espinet; Alice De Roia; Corinna Klein; Vanessa Vogel; Rienk Offringa; James A Williams; Martin Sprick; Richard P Harbottle
Journal:  Mol Ther Methods Clin Dev       Date:  2020-04-25       Impact factor: 6.698

5.  Generation of a tumor- and tissue-specific episomal non-viral vector system.

Authors:  Rudolf Haase; Terese Magnusson; Baowei Su; Florian Kopp; Ernst Wagner; Hans Lipps; Armin Baiker; Manfred Ogris
Journal:  BMC Biotechnol       Date:  2013-06-04       Impact factor: 2.563

6.  S/MAR sequence confers long-term mitotic stability on non-integrating lentiviral vector episomes without selection.

Authors:  Santhosh Chakkaramakkil Verghese; Natalya A Goloviznina; Amy M Skinner; Hans J Lipps; Peter Kurre
Journal:  Nucleic Acids Res       Date:  2014-01-27       Impact factor: 16.971

7.  Advances in the Development and the Applications of Nonviral, Episomal Vectors for Gene Therapy.

Authors:  Grace Elizabeth Mulia; Virginia Picanço-Castro; Eleana F Stavrou; Aglaia Athanassiadou; Marxa Leão Figueiredo
Journal:  Hum Gene Ther       Date:  2021-09-20       Impact factor: 5.695

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.